Singapore signals readiness to scale healthcare AI as HealthTechX Asia opens

Singapore has reaffirmed its commitment to AI-led healthcare transformation, with a senior government minister outlining the city-state’s readiness to move from foundation-building to national-scale deployment.

Speaking at the opening of HealthTechX Asia in Singapore on 6 May 2026, Tan Kiat How, Senior Minister of State for Digital Development and Information and Health, set out a three-part framework — structure, safeguards, and scaling — as the organising principles behind Singapore’s approach to healthtech adoption.

The speech comes as Singapore reaches a significant demographic threshold. The country formally became a super-aged society last year, with more than 20% of the population now aged 65 or above. Ministers have framed this as both a policy challenge and a driver of urgent healthcare reform.

Foundation first

Much of the minister’s address centred on Singapore’s investment in digital infrastructure as a precondition for AI deployment. He highlighted the National Electronic Health Record (NEHR), established in 2011, as the central data backbone, and noted that newly enacted legislation — the Health Information Act (HIA) — will from September 2027 require all licensed health providers to contribute patient data to the system.

The HEALIX platform, a cloud-based analytics system launched two years ago across the public healthcare sector, was cited as the next layer of that infrastructure, enabling AI tools to operate across a common data environment.

“The fundamentals are there,” Tan said, drawing on a building analogy to argue that technological ambition must be matched by structural readiness. “You want to be as tall as you can — reaching for the stars — but the foundation is important if you want to build tall and steadily.”

Scaling with evidence

On AI specifically, the minister pointed to use cases already in deployment — voice-to-text transcription, imaging diagnostics, and surgical robotics — and signalled that the government is prepared to roll out proven applications at the national level where return on investment is demonstrated.

Updated AI in Healthcare Guidelines (AIHGle 2.0), published earlier this year, were cited as providing practical guidance for innovators across healthcare, research, and industry.

Singapore also announced expanded subsidies for genetic testing programmes as part of its preventive care strategy, including forthcoming coverage for hereditary breast and ovarian cancer testing — an example of the government’s willingness to invest upstream in population health.

Governance and data security

The minister acknowledged that connecting health systems at scale compounds risk, and said the HIA would also require providers to implement cybersecurity and data security measures. Singapore is engaging healthcare and IT providers on implementation, with guidance and access to qualified cybersecurity consultants made available through government programmes.

The overall framing was one of cautious confidence — a government that has spent several years building regulatory and digital infrastructure and believes it is now positioned to act decisively.

“With the right structures and safeguards in place, we are ready to scale,” Tan said.

Note: HealthTechX Asia is a separate event organised by Clarion Events Asia and is not affiliated with HealthTechAsia (healthtechasia.co), the B2B digital health intelligence platform.

Author

  • Matthew Brady

    Matt Brady is an award-winning storyteller and strategic communications advisor.

    A native Englishman with global experience spanning China, Hong Kong, Iraq, Malaysia, Saudi Arabia, and the UAE, he founded HealthTechAsia and co-founded the non-profit Pul Alliance for Digital Health and Equity.

    He has led social media and communications initiatives for world leaders, corporations, and NGOs, and spearheaded editorial strategy for a portfolio of leading healthcare events and year-round publications — transforming coverage from print to digital — including Arab Health, Asia Health, Africa Health, FIME, and others. Earlier in his career, he held editorial roles at Microsoft and Johnson & Johnson.

    He received the 2021 Medical Travel Media Award from the Malaysia Healthcare Travel Council and a Guardian Student Media Award in 2000.

    Connect with Matt on LinkedIn: https://www.linkedin.com/in/matt-brady-0764992/

    View all posts

Discover more from HealthTechAsia

Subscribe to get the latest posts sent to your email.